EquityZen Growth Technology Fund LLC - Series 7
Raised
Pre-open
Investors
—
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 7 is a Delaware pooled investment fund filed by EquityZen, Inc., claiming exemptions under Rule 506(b) and Section 3(c)(1). This is an amended filing with no capital raise or investor count disclosed, indicating pre-open or initial setup status. Part of the EquityZen platform, which operates 1,891 related EDGAR entities focused on pre-IPO secondary market investments.
This vehicle follows the standard EquityZen platform structure: a Delaware-domiciled series LLC filing under 506(b) and 3(c)(1) exemptions, typical for pre-IPO secondary transactions. The platform convention leaves minimum investment and investor details undisclosed on Form D filings, with deal specifics managed through private placement documentation.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
N/A EquityZen, Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
